close
close
migores1

Sale Rumors Raise Health for Both Bausch + Lomb and Parent Bausch – Breakthrough Likely

This article was written by

Profile picture of Edmund Ingham

Edmund Ingham is a biotechnology consultant. He has been covering biotech, healthcare and pharmaceuticals for over 5 years and has produced detailed reports on over 1,000 companies. He heads the investment group Haggerston BioHealth.

The group is intended for both novice and experienced biotech investors. It provides catalysts to search and buy and sell ratings. It also provides product sales and forecasts for all major pharmaceuticals, forecasting, integrated financial statements, discounted cash flow analysis and market-to-market analysis. Learn more.

Analyst Disclosure: We do not have/we do not have shares, options or similar derivative positions in any of the mentioned companies, but we can initiate a beneficial long position by purchasing shares or purchasing call options or similar derivatives in BLCO, BHC over the next 72 years. hours. I wrote this article myself and it expresses my own opinions. I receive no compensation for this (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Looking for Alpha’s reveal: Past performance is no guarantee of future results. No recommendation or advice is given as to whether any investment is suitable for any particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, a US broker or investment adviser, or an investment bank. Our analysts are third-party authors that include both professional and individual investors who may not be authorized or certified by any institute or regulatory body.

Related Articles

Back to top button